The use of doxorubicine at low doses for elevation of LAK-activity toward explants and cells of MC-rhabdomyosarcoma and B16 melanoma resistant to doxorubicin. [electronic resource]
Producer: 20080605Description: 52-5 p. digitalISSN:- 1812-9269
- Animals
- Antibiotics, Antineoplastic -- administration & dosage
- Dose-Response Relationship, Drug
- Doxorubicin -- administration & dosage
- Drug Evaluation, Preclinical
- Drug Resistance, Neoplasm -- drug effects
- Killer Cells, Lymphokine-Activated -- drug effects
- Lymphocyte Activation -- drug effects
- Melanoma, Experimental -- drug therapy
- Mice
- Mice, Inbred BALB C
- Mice, Inbred C57BL
- Neoplasm Transplantation -- immunology
- Rhabdomyosarcoma -- drug therapy
- Tumor Escape -- drug effects
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.